Can Veinlite Reduce Complications of Peripheral Intravenous Catheter Placement in Children

Sponsor
Ege University (Other)
Overall Status
Completed
CT.gov ID
NCT05242068
Collaborator
(none)
139
1
2
13.1
10.6

Study Details

Study Description

Brief Summary

This study was conducted to investigate the use of Veinlite LED+ (TransLite, Sugar Land, Tex) to assist with PIC placement. The Veinlite uses LED (light-emitting diode) lights to enhance the visualization of veins by using orange and red color that are absorbed in venous blood.

The investigators' hypothesis for this study was that the vein imaging would reduce the complications related to catheter and the pain that the participants would feel.

Condition or Disease Intervention/Treatment Phase
  • Device: Veinlite
  • Other: Standard care
N/A

Detailed Description

Peripheral Intravenous Catheterization (PIC) introduces multiple risks and potential morbidities. Patients with PIC-associated complications have longer length of stay, higher clinical and economic burden, and greater risk of death than patients without. The most serious complications due to intravenous (IV) catheters are infiltration and extravasation.

The primary endpoint was to evaluate whether Veinlite LED+ would prevent catheter-related complications.

The secondary endpoint were;

  1. to evaluate the efficacy of the vein imaging device on pediatric pain during intravenous catheterization

  2. to evaluate the efficacy of the vein imaging device on catheter dwell time.

Study Design

Study Type:
Interventional
Actual Enrollment :
139 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study was a prospective randomized controlled clinical study of children treated in a pediatric surgical ward who required PIC. The aim of the research was to evaluate whether the Veinlite would prevent catheter-related complicationsThis study was a prospective randomized controlled clinical study of children treated in a pediatric surgical ward who required PIC. The aim of the research was to evaluate whether the Veinlite would prevent catheter-related complications
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Can Veinlite Reduce Complications of Peripheral Intravenous Catheter Placement in Children: Preliminary Results.
Actual Study Start Date :
Dec 1, 2018
Actual Primary Completion Date :
Aug 6, 2019
Actual Study Completion Date :
Jan 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Standard care of group

Patients in standard care of group received traditional peripheral intravenous catheterization

Other: Standard care
Patients received standard intravenous catheterization.

Experimental: Veinlite group

Patients in veinlite group received peripheral intravenous catheterization with Veinlite

Device: Veinlite
Use of vein imaging device for visualization of veins during peripheral IV placement

Outcome Measures

Primary Outcome Measures

  1. Reducing number of complications related with peripheral intravenous catheter [Duration of catheter dwell time (up to 168 hours)]

    Reducing number of complications related with peripheral intravenous catheter during treatment

Secondary Outcome Measures

  1. Pain scores during peripheral intravenous catheterization [Immediately after IV placement]

    Pain scores by child, nurse, and parent. In this study, numerical rating score was used for determine pain level. The numeric rating scale is one of the most commonly used to obtain self-reports of pain intensity in school-age children, adolescents, and adults. The numerical rating scale (NRS) requires the child to rate her/his pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable.

  2. Catheter dwell time [Up to 168 hours (1 week)]

    Intravenous catheter survival time during the treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children aged between 5 and 18

  • Children with DIVA (Difficult intravenous access score) score 4 or more

  • That the child and the parent speak Turkish

Exclusion Criteria:
  • needing urgent treatment

  • a critical health condition

  • That the child or the parent has a communication problem

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ege University İzmir Turkey

Sponsors and Collaborators

  • Ege University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ayşe Kahraman, associate professor, Ege University
ClinicalTrials.gov Identifier:
NCT05242068
Other Study ID Numbers:
  • E.314064
First Posted:
Feb 16, 2022
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayşe Kahraman, associate professor, Ege University

Study Results

No Results Posted as of Feb 16, 2022